Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 1:18 PM
Ignite Modification Date:
2025-12-26 @ 1:18 PM
NCT ID:
NCT01818206
Eligibility Criteria:
Inclusion Criteria:
* Informed consent
* Affiliated or benefit from a disease insurance regimen
* Men and women
* Aged from at least 6 years old
* Confirmed Diagnosis of cystic fibrosis based on presence of 2 mutations of CFTR gene and/or 2 positive tests of sweat chloride and/or 2 measures of pathologic difference of nasal potential associated to cystic fibrosis clinical signs.
* Patients able to produce sputum
* Pseudomonas aeruginosa Chronic infected patients
Exclusion Criteria:
* Simultaneous participation to another project on anti-infection, anti-inflammatory or modificating agents
* Subjet in exclusion period
* Law protected patient
* Realisation of sputum production is contra-indicated
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Study:
NCT01818206
Study Brief:
Protocol Section:
NCT01818206